Compass Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Tax Withholding | 44,025 | $4.83 | $212,641 | Nov 16, 2025 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 10,000 | $2.11 | $21,100 | May 27, 2025 |
| GORDON CARL L | — | Sale | 3,571,428 | $1.59 | $5,678,571 | Apr 9, 2025 |
| OrbiMed Capital GP VI LLC | — | Sale | 3,571,428 | $1.59 | $5,678,571 | Apr 9, 2025 |
| Anderman Jonathan | Gen Counsel & Corporate Sec | Purchase | 20,000 | $1.54 | $30,800 | Apr 7, 2025 |
| Lerner Neil | CHIEF ACCOUNTING OFFICER | Purchase | 20,000 | $1.42 | $28,400 | Apr 7, 2025 |
| Schuetz Thomas J. | CEO | Tax Withholding | 41,687 | $3.50 | $145,905 | Feb 8, 2025 |
| Schuetz Thomas J. | CEO | Tax Withholding | 58,054 | $1.86 | $107,980 | Jan 9, 2025 |
| Shin Barry | CFO | Award / Grant | 400,000 | $1.65 | $660,000 | Dec 9, 2024 |
| Bisker-Leib Vered | CHIEF EXECUTIVE OFFICER | Tax Withholding | 49,198 | $1.45 | $71,337 | Feb 8, 2024 |
| Schuetz Thomas J. | PRESIDENT | Tax Withholding | 44,782 | $1.45 | $64,934 | Feb 8, 2024 |
| Bisker-Leib Vered | Chief Executive Officer | Award / Grant | 1,753,125 | $1.93 | $3,383,531 | Jan 9, 2024 |
| Schuetz Thomas J. | President of R&D | Award / Grant | 637,500 | $1.93 | $1,230,375 | Jan 9, 2024 |
| Bisker-Leib Vered | Chief Operating Officer | Tax Withholding | 64,415 | $1.50 | $96,623 | Nov 17, 2023 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Tax Withholding | 44,025 | $1.50 | $66,038 | Nov 17, 2023 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 10,000 | $3.37 | $33,700 | Mar 10, 2023 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 20,000 | $3.98 | $79,600 | Feb 27, 2023 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 20,000 | $3.86 | $77,200 | Feb 15, 2023 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Award / Grant | 500,000 | — | — | Feb 8, 2023 |
| Bisker-Leib Vered | Chief Operating Officer | Award / Grant | 400,000 | — | — | Feb 8, 2023 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 20,000 | $4.05 | $81,000 | Jan 31, 2023 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 20,000 | $4.19 | $83,800 | Jan 24, 2023 |
| Bisker-Leib Vered | Chief Operating Officer | Sale | 9,569 | $4.30 | $41,147 | Nov 22, 2022 |
| Bisker-Leib Vered | Chief Operating Officer | Sale | 16,035 | $4.34 | $69,592 | Nov 18, 2022 |
| ORBIMED ADVISORS LLC | — | Purchase | 402,000 | $3.21 | $1,290,420 | Nov 8, 2022 |
| GORDON CARL L | — | Purchase | 402,000 | $3.21 | $1,290,420 | Nov 8, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 10,000 | $2.32 | $23,200 | Sep 28, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 15,000 | $2.27 | $34,050 | Sep 26, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 15,000 | $3.03 | $45,450 | Sep 7, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 15,000 | $2.83 | $42,450 | Sep 1, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 15,000 | $3.05 | $45,750 | Aug 17, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 15,000 | $2.64 | $39,600 | Aug 10, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 15,000 | $2.58 | $38,700 | Aug 1, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 20,000 | $2.80 | $56,000 | Jun 21, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 20,000 | $2.34 | $46,800 | Jun 16, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 30,000 | $2.29 | $68,700 | Jun 13, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 30,000 | $2.83 | $84,900 | Jun 6, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 20,000 | $3.03 | $60,600 | Jun 1, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 20,000 | $3.04 | $60,800 | May 26, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 18,355 | $2.72 | $49,926 | May 23, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 20,215 | $2.47 | $49,931 | May 17, 2022 |
| GORDON CARL L | — | Purchase | 64,700 | $1.79 | $115,813 | May 13, 2022 |
| ORBIMED ADVISORS LLC | — | Purchase | 30,722 | $2.49 | $76,498 | May 11, 2022 |
| GORDON CARL L | — | Purchase | 10,200 | $1.63 | $16,626 | May 10, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Purchase | 27,836 | $1.80 | $50,105 | May 10, 2022 |
| OrbiMed Capital GP V LLC | — | Purchase | 24,447 | $1.60 | $39,115 | May 6, 2022 |
| Schuetz Thomas J. | Chief Executive Officer | Award / Grant | 600,000 | — | — | Nov 16, 2021 |
| Bisker-Leib Vered | Chief Operating Officer | Award / Grant | 600,000 | — | — | Nov 16, 2021 |
| GORDON CARL L | — | Purchase | 3,571,428 | $3.50 | $12,499,998 | Nov 4, 2021 |
| OrbiMed Genesis GP LLC | — | Purchase | 3,571,428 | $3.50 | $12,499,998 | Nov 4, 2021 |